Back to GEN Stock Lookup

Genesis HealthCare (GEN) –

Aug 23, 2016 07:05 AM Genmab Announces European Regulatory Submission for Daratumumab in Relapsed Multiple Myeloma
Aug 17, 2016 03:40 PM Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Relapsed Multiple Myeloma
Aug 11, 2016 07:45 AM GeneNews Announces Q2-2016 Financial Results
Aug 10, 2016 02:29 PM Genmab, Gilead (GILD) Enter Commercial License Agreement for DuoBody Technology
Aug 10, 2016 01:07 PM Genmab Enters Commercial License Agreement with Gilead for DuoBody(R) Technology
Aug 9, 2016 11:11 AM Genmab Announces Financial Results for the First Half of 2016 and Improves 2016 Financial Guidance
Aug 5, 2016 12:43 PM Form 10-Q Genesis Healthcare, Inc. For: Jun 30
Aug 5, 2016 12:35 PM Form 4 Genesis Healthcare, Inc. For: Aug 03 Filed by: Reis David A
Aug 4, 2016 04:52 PM Genesis HealthCare (GEN) Misses Q2 EPS by 27c
Aug 4, 2016 04:36 PM Form 8-K Genesis Healthcare, Inc. For: Aug 04
Aug 4, 2016 04:35 PM Genesis Healthcare Reports Second Quarter 2016 Results
Aug 1, 2016 08:30 AM Form 8-K Genesis Healthcare, Inc. For: Jul 29
Aug 1, 2016 08:30 AM Genesis HealthCare Makes Significant Headway In Capital Strengthening Initiatives
Aug 1, 2016 08:06 AM Form SC 13D/A Genesis Healthcare, Inc. Filed by: Fishman Steven E.
Jul 29, 2016 04:11 PM Form 424B7 Genesis Healthcare, Inc.
Jul 26, 2016 04:30 PM GeneNews Provides Financing Update
Jul 25, 2016 08:15 PM Daratumumab Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration in Combination with Standard of Care Regimens for Previously Treated Multiple Myeloma
Jul 18, 2016 03:58 PM Form SC 13D/A Genesis Healthcare, Inc. Filed by: Fishman Steven E.
Jul 12, 2016 03:15 PM Form 4 Genesis Healthcare, Inc. For: Jul 07 Filed by: Reis David A
Jun 30, 2016 06:30 PM GeneNews Announces Election of Directors
Jun 23, 2016 10:33 AM Genmab Provides Update on Marketing Authorization Application for Arzerra(r) (ofatumumab) as Maintenance Therapy for Patients with Relapsed CLL
Jun 16, 2016 10:30 AM GeneNews Meets TSX Continued Listing Requirements
Jun 16, 2016 07:30 AM GeneNews MCTO Lifted
Jun 15, 2016 07:30 AM GeneNews Announces Filing of Q1-2016 Financial Results
Jun 13, 2016 04:18 PM Genesis HealthCare Names Steve Saville President Of CareerStaff Unlimited
Jun 13, 2016 12:53 PM Form 8-K Genesis Healthcare, Inc. For: Jun 08
Jun 9, 2016 06:58 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: SCHAFER GLENN S
Jun 9, 2016 06:44 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: Whitman Arnold M
Jun 9, 2016 06:00 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: Reis David A
Jun 9, 2016 05:44 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: MCKEON JAMES V
Jun 9, 2016 05:33 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: Hartman Robert
Jun 9, 2016 05:08 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: Fishman Steven E.
Jun 9, 2016 04:30 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: FISH ROBERT H
Jun 9, 2016 03:51 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: DEPODESTA JOHN
Jun 9, 2016 03:29 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: BLOEM JAMES H
Jun 9, 2016 02:31 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: Sherman Michael Scott
Jun 9, 2016 02:16 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: REITZ ROBERT A
Jun 9, 2016 01:55 PM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: Reifsnyder JoAnne Susan
Jun 9, 2016 11:43 AM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: Hirschfeld Daniel Allen
Jun 9, 2016 11:05 AM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: HAGER GEORGE V JR
Jun 9, 2016 10:27 AM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: DiVittorio Thomas
Jun 9, 2016 10:00 AM Form 4 Genesis Healthcare, Inc. For: Jun 08 Filed by: Young Stephen Scott
Jun 9, 2016 07:30 AM GeneNews Secures CAD $5 Million Capital Commitment From GEM Global Yield Fund
Jun 8, 2016 04:43 PM Twelve Genesis HealthCare Centers Receive Bronze National Quality Award
Jun 6, 2016 04:04 PM Form 144 Genesis Healthcare, Inc. Filed by: HAGER GEORGE V JR
Jun 2, 2016 01:49 AM Genmab Announces Phase III Studies of Ofatumumab in Relapsing Multiple Sclerosis
May 30, 2016 10:59 AM Genmab Achieves USD 30 Million Milestone in DARZALEX(r) (daratumumab) Collaboration with Janssen
May 27, 2016 06:00 PM GeneNews Announces Full Year 2015 Financial Results
May 23, 2016 07:15 AM Genmab Announces European Conditional Marketing Authorization for DARZALEX(r) (daratumumab) for Multiple Myeloma
May 20, 2016 08:30 AM GeneNews Issues Trading Status Clarification

Back to GEN Stock Lookup